Abstract
The murine monoclonal antibody YB5.B8 (CD117) identifies a transmembrane tyrosine kinase receptor encoded by the human c-kit proto-oncogene. In this study we investigated the expression of c-kit on different types of acute leukemia to determine the degree of specificity and sensitivity of this marker for the myeloid and lymphoid lineages. C-kit was positive in over half of the 115 cases of acute leukemia studied. Overall, two thirds of AML cases expressed c-kit, whereas only one of 23 ALL patients was c-kit positive. C-kit was also positive in 16 of 19 cases of myeloid blast crisis of myeloproliferative disorders and negative in four with a lymphoid phenotype. There was no correlation between c-kit expression and the degree of myeloid differentiation by FAB subtypes or other markers. We conclude that c-kit is a specific marker for the myeloid lineage, which is expressed early during hematopoietic differentiation and can aid the diagnosis of AML in difficult cases. More patients need to be tested to establish whether the expression of c-kit may define AML subgroups of prognostic significance.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ashman LK, Roberts MM, Gadd SJ, Cooper SJ, Juttner CA (1988) Expression of a 150-kD cell surface antigen identified by monoclonal antibody YB5.B8 is associated with poor prognosis in acute non-lymphoblastic leukaemia. Leuk Res 12:923–928
Ashman LK, Cambareri AC, Bik TL, Levinsky RJ, Juttner CA (1991) Expression of the YB5.B8 antigen (c-kit proto-oncogene product) in normal human bone marrow. Blood 78:30–37
Barclay AN, Birkeland ML, Brown HM, Beyers AD, Davis SJ, Somoza C, Williams AF (1993) The leucocyte antigen. Facts book. Academic, Harcourt Brace Jovanovich, London
Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C (1976) Proposals for the classification of the acute leukaemias: French-American-British (FAB) cooperative. Br J Haematol 33:451–458
Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, et al (1985) Proposed revised criteria for the classification of acute myeloid leukaemia. Ann Intern Med 103:620–625
Broudy VC, Smith FO, Lin N, Zsbo KM, Egrie J, Bernstein ID (1992) Blasts from patients with acute myelogenous leukemia express functional receptors for stem cell factor. Blood 80:60–67
Buccheri V, Shetty V, Yoshida N, Morilla R, Matutes E, Catovsky D (1992) The rule of an anti-myeloperoxidase antibody in the diagnosis and classification of acute leukaemia: a comparison with light and electron microscopy cytochemistry. Br J Haematol 80:62–68
Buccheri V, Matutes E, Dyer M, Catovsky D (1993) Lineage commitment in biphenotypic acute leukemia. Leukemia 7:919–927
Bühring HJ, Ullrich A, Schaudt K, Möller CA, Busch FW (1991) The product of the protooncogene c-kit (Pl45c-kit) is a human bone marrow surface antigen of hemopoietic precursor cells which is expressed on a subset of acute non-lymphoblastic leukemic cells. Leukemia 5:854–860
Catovsky D, Matures E (1992) The classification of acute leukaemia. Leukaemia 6 [Suppl 2]: 1–6
Cordell JL, Falini B, Erber WN, Mason DY (1984) Immunoenzymatic labelling of monoclonal antibodies using immune complexes of alkaline phosphatase (APAAP complexes). J Histochem Cytochem 32:219–229
Crosier PS, Ricciardi ST, Hall LR, Vitas MR, Clark SC, Crosier KE (1993) Expression of isoforms of the human receptor tyrosine kinase c-kit in leukemic cell lines and acute myeloid leukemia. Blood 82:1151–1158
de Vries P, Brasel KA, Mckenna HJ, Williams DE, Watson JD (1992) Thymus reconstitution by c-kit-expressing hematopoietic stem cells purified from adult mouse bone marrow. J Exp Med 176:1503–1509
Drexler HG, Theil E, Ludwig W-D (1991) Review of the incidence and clinical relevance of myeloid antigen-positive acute lymphoblastic leukemia. Leukemia 5:637–645
Farahat N, van der Plas D, Praxedes M, Morilla R, Matutes E, Catovsky D (1994) Demonstration of cytoplasmic and nuclear antigens in acute leukaemia using flow cytometry. J Clin Pathol 47:843–849
Gadd SJ, Ashaman LK (1985) A murine monoclonal antibody specific for a cell-surface antigen expressed by a sub-group of human myeloid leukemias. Leuk Res 9:1329–1336
Huang E, Nocka K, Beier DR, Chu TY, Buck J, Lahm HW, Wellner D, Leder P, Besmer P (1990) The hematopoietic growth factor KL is encoded by the S/locus and is the ligand of the c-kit receptor, the gene product of the W locus. Cell 63:225–233
Ikeda H, Kanakura Y, Tamaki T, Kuriu A, Kitayama H, Ishikawa J, Kanayama Y, Yonezawa T, Tarui S, Griffin J (1991) Expression and functional role of c-kit in acute myeloblastic leukaemia. Blood 78:2962–2968
Knapp W, Strobl H, Majdic O (1994) Flow cytometric analysis of cell-surface and intracellular antigens in leukemia diagnosis. Cytometry 18:187–198
Kubota A, Okamura S, Shimoda K, Ikematsu W, Otsuka T, Niho Y (1995) Analysis of c-kit expression of human erythroleukemia cell line, HEL: clonal variation and relationship with erythroid and megakaryocytic phenotype. Leuk Res 19:283–290
Lerner NB, Nocka KH, Cole SR, Qui F, Strife A, Ashman LK, Besmer P (1991) Monoclonal antibody YB5.B8 identifies the human c-kit protein product. Blood 77:1876–1883
Macedo A, Orfao A, Martínez A, Vidriales MB, Valverde B, López-Berges MC, San Miguel JF (1995) Immunophenotype of c-kit cells in normal human bone marrow: implications for the detection of minimal residual disease in AML. Br J Haematol 89:338–341
Moore M (1991) Clinical implications of positive and negative hematopoietic stem cell regulators. Blood 78:1–19
Nishii K, Kita K, Miwa H, Kawakami K, Nakase K, Masuya M, Morita N, Omay S, Otsuji N, Fukumoto M, Shirakawa S (1992) C-kit gene expression in CD7-positive acute lymphoblastic leukaemia: close correlation with expression of myeloid-associated antigen CD13. Leukemia 6:662–668
Reuss-Borst MA, Buhring HJ, Schmidt H, Muller CA (1994) AML: immunophenotypic heterogeneity and prognostic significance of c-kit expression. Leukemia 8:258–263
Rolink A, Melchers F (1993) Generation and regeneration of cells of the B-lymphocyte lineage. Curr Opin Immunol 5:207–217
Rolink A, Streb M, Nishikawa SI, Melchers F (1991) The ckit-encoded tyrosine kinase regulates the proliferation of eraly pre-B cells. Eur J Immunol 21:2609–2612
Strobl H, Takimoto M, Majdic O, Hicker P, Knapp W (1992) Antigenic analysis of human haemopoietic progenitor cells expressing the growth factor receptor c-kit. Br J Haematol 82:287–294
Tjonnfjord G, Veiby O, Steen R, Egeland T (1993) T lymphocyte differentiation in vitro from adult human prethymic CD34+ bone marrow cells. J Exp Med 177:1531–1539
Wang C, Curtis JE, Geissler EN, Culloch EA, Minden MD (1989) The expression of the proto-oncogene c-kit in the blast cells of acute myeloblastic leukemia. Leukemia 3:699–702
Witte O (1990) Steel locus defines new multipotent growth factor. Cell 63:5–6
Zsebo KM, Williams DA, Geissler EN, Broudy VC, Martin FH, Atkins HL, Hsu RY, Birkett NC, Okino KH, Murdock DC, et al (1990) Stem cell factor is encoded at the S1 locus of the mouse and is the ligand for the c-kit tyrosine kinase receptor. Cell 63:213–224
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Valverde, L.R., Matutes, L., Farahat, N. et al. C-kit receptor (CD0117) expression in acute leukemia. Ann Hematol 72, 11–15 (1996). https://doi.org/10.1007/BF00663010
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00663010